Imaging in ankylosing spondylitis

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 3, 2006, Pages 507-519

  Maksymowych, Walter P ^a   Landewé, Robert ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ankylosing spondylitis; magnetic resonance imaging; plain radiography

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ANKYLOSING SPONDYLITIS; BONE MARROW DISEASE; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; SACROILIAC JOINT; SACROILIITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPINE RADIOGRAPHY; SYMPTOM; TIME; TREATMENT OUTCOME;

HUMANS; MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; SPINE; SPONDYLITIS, ANKYLOSING;

EID: 33744908039     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.03.006     Document Type: Review

References (38)

1. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 27 (1984) 361-368
2. Feldtkeller E., Khan M.A., Van Der Heijde D., et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatology International 23 (2003) 61-66
3. Van Tubergen A., Heuft-Dorenbosch L., Schulpen G., et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?. Annals of the Rheumatic Diseases 62 (2003) 519-525
4. Wanders A.J., Landewé R.B., Spoorenberg A., et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter. Arthritis and Rheumatism 50 (2004) 2622-2632
5. Wanders A., Landewé R., Dougados M., et al. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?. Annals of the Rheumatic Diseases 64 (2005) 988-994
6. MacKay K., Mack C., Brophy S., and Calin A. The bath ankylosing spondylitis radiology index (BASRI): a new, validated approach to disease assessment. Arthritis and Rheumatism 41 (1998) 2263-2270
7. Averns H.L., Oxtoby J., Taylor H.G., et al. Radiological outcome in ankylosing spondylitis: use of the stoke ankylosing spondylitis spine score (SASSS). British Journal of Rheumatology 35 (1996) 373-376
8. Creemers M.C., Franssen M.J., van't Hof M.A., et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Annals of the Rheumatic Diseases 64 (2005) 127-129
9. Spoorenberg A., de Vlam K., van der Linden S., et al. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. The Journal of Rheumatology 31 (2004) 125-132
10. Wanders A., Heijde D., Landewé R., et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis and Rheumatism 52 (2005) 1756-1765
11. Francois R.J., Gardner D.L., Degrave E.J., and Bywaters E.G.L. Histopathologic evidence that sacroilitis in ankylosing spondylitis is not merely enthesitis. Arthritis and Rheumatism 43 (2000) 2011-2024
12. Battafarano D.F., West S.G., Rak K.M., et al. Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis. Seminars in Arthritis and Rheumatism 23 (1993) 161-176
13. Puhakka K.B., Jurik A.G., Egund N., et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiologica 44 (2003) 218-229
14. Blum U., Buitrago-Tellez C., Mundinger A., et al. Magnetic resonance imaging (MRI) for detection of active sacroiliitis-a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. The Journal of Rheumatology 23 (1996) 2107-2115
15. Wittram C., Whitehouse G.H., Williams J.W., and Bucknall R.C. A comparison of MR and CT in suspected sacroiliitis. Journal of Computer Assisted Tomography 20 (1996) 68-72
16. Ahlstrom H., Feltelius N., Nyman R., and Hallgren R. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis and Rheumatism 33 (1990) 1763-1769
17. Muche B., Bollow M., Francois R.J., et al. Anatomic structures involved in early- and late-stage sacroiliitis in spondyloarthritis. Arthritis and Rheumatism 48 (2003) 1374-1384
18. Braun J., Baraliakos X., Golder W., et al. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Annals of the Rheumatic Diseases 63 (2004) 1046-1055
19. Baraliakos X., Landewé R., Hermann K.G., et al. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Annals of the Rheumatic Diseases 64 (2005) 730-734
20. Marzo-Ortega H., McGonagle D., O'Connor P., et al. Fat suppressed MRI in spinal disease in early spondyloarthropathy. Annals of the Rheumatic Diseases 58 supplement (1999) 116
21. Bollow M., Fischer T., Reisshauer H., et al. Quantitative analyses of sacroiliac biopsies in spondylarthropathies: T cells and macrophages predominate in early and active sacroiliitis -cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Annals of the Rheumatic Diseases 59 (2000) 135-140
22. Braun J., Bollow M., Seyrekbasan F., et al. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. The Journal of Rheumatology 23 (1996) 659-664
23. Puhakka K.B., Jurik A.G., Schiottz-Christensen B., et al. Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology 43 (2004) 234-237
24. Oostveen J., Prevo R., den Boer J., and van de Laar M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. The Journal of Rheumatology 26 (1999) 1953-1958
25. Braun J., Baraliakos X., Golder W., et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab. Evaluation of a new scoring system. Arthritis and Rheumatism 48 (2003) 1126-1136
26. Maksymowych W.P., Inman R.D., Salonen D., et al. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis and Rheumatism 53 (2005) 502-509
27. van der Heijde D.M., Landewé R.B., Hermann K.G., et al. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7. The Journal of Rheumatology 32 (2005) 2042-2047
28. Puhakka K.B., Jurik A.G., Egund N., et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiologica 44 (2003) 218-229
29. Maksymowych W.P., Inman R.D., Salonen D., et al. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis and Rheumatism 53 (2005) 703-709
30. Landewé R.B., Hermann K.G., van der Heijde D.M., et al. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment. The Journal of Rheumatology 32 (2005) 2050-2055
31. Braun J., Baraliakos X., Golder W., et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis and Rheumatism 48 (2003) 1126-1136
32. Baraliakos X., Davis J., Tsuji W., and Braun J. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis and Rheumatism 52 (2005) 1216-1223
33. Rudwaleit M., Baraliakos X., Listing J., et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Annals of the Rheumatic Diseases 64 (2005) 1305-1310
34. Maksymowych W.P., Inman R.D., Salonen D., et al. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis and Rheumatism 53 (2005) 502-509
35. Maksymowych W.P., Dhillon S.S., Park R., and Lambert R.G.W. Validation of the spondyloarthritis research consortium of Canada (SPARCC) MRI spinal inflammation index: how many spinal segments are optimal?. Arthritis and Rheumatism 52 supplement 9 (2005) S633
36. Baraliakos X., Hermann K.G., Landewé R., et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Annals of the Rheumatic Diseases 64 (2005) 1141-1144
37. Hermann K.G., Landewé R.B., Braun J., and van der Heijde D.M. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?. The Journal of Rheumatology 32 (2005) 2056-2060
38. Braun J., Pham T., Sieper J., et al. ASAS Working Group. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 62 (2003) 817-824